Medical Weight Loss for Bowie, Maryland Residents

Bowie, Maryland residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Bowie through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Start this week from Bowie: book a video visit, complete your intake, and if you are a fit, your compounded medication ships to your Maryland door. No travel to California required. Doctor review just $119 (medication separate).

Why Bowie Residents Choose New Hope Weight Loss

We are built for people who would rather not deal with insurance at all. New Hope is cash-pay friendly, so there are no prior authorizations, no denials, and no waiting on a carrier to decide what you are allowed to try. Patients in Bowie pay a flat physician fee of $119 and a clear monthly medication price, and we accept HSA, FSA, Klarna, and Affirm so the cost can fit your budget without a fight.

If you are searching for medical weight loss in Bowie, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.

Telehealth is what lets us care for Bowie, Maryland from a single office in Costa Mesa, so you get Dr. Sharma's full attention without rearranging your day around an appointment across town. We care for patients throughout Bowie and the greater Prince George's County area of the DC suburbs. Refills are tracked for you and reshipped on schedule, so nothing lapses while you are busy living your life in Bowie.

You can start this week from anywhere in Maryland, because telehealth removes the drive, the parking, and the weeks of waiting that a local clinic would require. Your compounded semaglutide or tirzepatide ships directly to your Bowie address in an insulated cold-pack box, so it stays stable in transit. New Hope Weight Loss serves patients throughout Maryland entirely by telehealth from our Costa Mesa, California clinic, delivering physician-supervised GLP-1 programs without an office visit.

GLP-1 Weight Loss Programs Available

The 90-Day Metabolic Reset (Semaglutide)

Think of this as a focused three-month plan. Semaglutide carries the same active ingredient as Wegovy and Ozempic, and the branded versions averaged about 15 to 17 percent body-weight loss in trials. Pricing is from $166/mo, with the full 90 days at $499, and Dr. Sharma adjusts your dose along the way. Compounded semaglutide is not FDA-approved, not brand-identical, and individual results vary.

Advanced Program (Tirzepatide)

From $233/mo, tirzepatide engages two metabolic pathways, GLP-1 and GIP. Trials of the branded drug reached up to 22.5 percent loss at higher qualifying doses, a best-case figure rather than the norm. Shares an active ingredient with Mounjaro and Zepbound.

Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm welcome for Bowie telehealth patients.

How Telehealth Works for Bowie

Think of it as four easy moments. You begin with an online intake quiz that asks about your weight, your health history, and what you want to achieve. Dr. Anjmun Sharma then reviews your answers and meets you by secure video, generally within 48 hours, to talk honestly about whether compounded semaglutide or tirzepatide could help you. If she prescribes one, a state-licensed 503(a) pharmacy fills it and ships it to your Bowie address in protective cold-pack packaging. Finally, your follow-up care is delivered by video, so people throughout can stay on plan without ever sitting in a waiting room.

Frequently Asked Questions, Bowie

Can people from Bowie get treated by New Hope Weight Loss?

Absolutely. We operate one physical clinic in Costa Mesa, California, and we provide telehealth care to Bowie, Maryland. Whether you are in Bowie and the greater Prince George's County area of the DC suburbs or elsewhere in the area, the path is the same. Dr. Anjmun Sharma meets you by video and confirms if a compounded GLP-1 program is right for you.

Do Bowie patients ever have to come into the office?

Never. Care is delivered entirely through telehealth, which means Bowie residents stay home for consults, follow-ups, and questions. Once Dr. Sharma approves you, your compounded semaglutide or tirzepatide is mailed to Bowie inside cold-pack packaging that holds the right temperature in transit.

What is the cost breakdown for Bowie?

You pay $119 for the physician review. Semaglutide begins at $166 a month, or $499 across 90 days, and tirzepatide begins at $233 a month. Medication is a separate charge. We accept HSA, FSA, Klarna, and Affirm payments, and there is no distance surcharge applied to anyone in Bowie.

What areas of Bowie do you serve?

We serve patients from across Bowie by telehealth, including Bowie and the greater Prince George's County area of the DC suburbs.

Who qualifies for the program in Bowie?

Eligibility for Bowie patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.

Bowie Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Bowie, Maryland by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.